Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-15-009141
Filing Date
2015-11-27
Accepted
2015-11-27 16:16:41
Documents
1
Effectiveness Date
2015-11-27

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS defa14a1115_actiniumpharma.htm DEFA14A 34569
  Complete submission text file 0001213900-15-009141.txt   35660
Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36374 | Film No.: 151258198
SIC: 2834 Pharmaceutical Preparations